Company intelligence / Profile preview

Eagle Technologies

Woodcliff Lake, New Jersey, United Stateseagletechnologiesbbwpc.wpcomstaging.com ↗

Ownership: Private
Employees: ~135
Development stage: Other

Overview

Eagle Pharmaceuticals is a commercial-stage pharmaceutical company focused on developing and commercializing innovative products in oncology, critical care, and orphan diseases. Their portfolio includes several approved drugs, and they leverage the 505(b)(2) regulatory pathway for drug development, specializing in injectable formulations.

Therapeutic areas: PulmonologyOncologyOtherGastroenterologyInfectious Diseases
Modalities: Small moleculeBiologicDrug-device combination products
Industry: Biotech

Beyond the preview

Go deeper on Eagle Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eagle Technologies.

Explore the full profile